Lamotrigine-Valproic Acid Interaction Leading to Stevens-Johnson Syndrome

Case Reports in Medicine
Marta VázquezCarlos Azambuja

Abstract

Lamotrigine (LTG) is currently indicated as adjunctive therapy for focal and generalized tonic-clonic seizures and for treatment of bipolar disorder and neuropathic pain. A common concern with LTG in children is the frequency of appearance of skin rash. The intensity of this adverse effect can vary from transient mild rash to Stevens-Johnson syndrome (SJS), which can be fatal mainly when LTG is coadministered with valproic acid (VPA). Hereby, we present the case of an 8-year-old boy who suffered from SJS and other complications two weeks after LTG was added to his VPA treatment in order to control his seizures. VPA is known to decrease LTG clearance via reduced glucuronidation. In this case, the minor elimination pathway of LTG would play a more important role, and the formation of an arene oxide metabolite would be enhanced. As this reactive metabolite is detoxified mainly by enzymatic reactions, involving microsomal epoxide hydrolase and/or GSH-S-transferases and these enzymes are polymorphically expressed in humans, arene oxide toxicity is increased when epoxide hydrolase or GSH-S-transferases is either defective or inhibited or a depletion of intracellular glutathione levels is taking place. VPA can cause inhibition of epox...Continue Reading

References

Aug 16, 1974·Science·D M Jerina, J W Daly
Sep 16, 2000·Pharmacology & Toxicology·S KleeF R Ungemach
Nov 23, 2000·Chemical Research in Toxicology·J L MaggsB K Park
Nov 26, 2002·The Journal of Clinical Psychiatry·Joseph R CalabreseVivek Kusumakar
Mar 28, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Andrew RowlandJohn O Miners
Apr 6, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Wei Lu, Jack P Uetrecht
Aug 4, 2009·European Journal of Drug Metabolism and Pharmacokinetics·Mladena LalicMomir Mikov
Jul 1, 2010·The Annals of Pharmacotherapy·Jerrold PerrottPeter J Zed
Apr 8, 2011·Molecular Medicine Reports·Hatice PinarbasiErgun Pinarbasi
May 4, 2013·Clinical Pharmacokinetics·Domenico Italiano, Emilio Perucca
Jun 25, 2013·Clinical Biochemistry·Radu M Nanau, Manuela G Neuman
Aug 13, 2013·Handbook of Clinical Neurology·Nanna Brix FinnerupTroels Staehelin Jensen
Aug 16, 2013·The Journal of Clinical Psychiatry·Jennifer G ReidLori L Altshuler
Nov 5, 2013·The American Journal of Psychiatry·Crystal T ClarkKatherine L Wisner
May 29, 2014·BioMed Research International·Marta VázquezIvette Olano
Aug 7, 2014·JAMA : the Journal of the American Medical Association·Wen-Hung ChungUNKNOWN Japan Pharmacogenomics Data Science Consortium
Dec 18, 2014·Epileptic Disorders : International Epilepsy Journal with Videotape·Gaetano Zaccara, Emilio Perucca
Apr 29, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Xiang-qing WangSen-yang Lang
May 16, 2015·Neurología : publicación oficial de la Sociedad Española de Neurología·I Fricke-GalindoM López-López
Jun 14, 2015·BMJ Open·Oluwaseun EgunsolaHelen M Sammons
Feb 24, 2016·Brain and Behavior·Anton WarshavskyRonit Gilad
Mar 5, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Maria RosaHugues Chanteux
Mar 22, 2016·BioMed Research International·Cecilia MaldonadoMarta Vázquez
Nov 9, 2016·Expert Review of Clinical Pharmacology·Venkata Ramesh YasamM J Nanjan
Apr 21, 2017·The Journal of International Medical Research·Cecilia MaldonadoMarta Vázquez

❮ Previous
Next ❯

Citations

Aug 29, 2020·BioMed Research International·Marta VázquezPaula Schaiquevich
Jan 23, 2021·CNS Drugs·Adam Strzelczyk, Susanne Schubert-Bast

❮ Previous
Next ❯

Methods Mentioned

BETA
Genotyping
Assay

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.